Latest News and Press Releases

- Powerful and precise compact instrument enables Enzo to offer a  complete solution to advance drug discovery - Microplate reader can be retrofitted for point-of-care clinical testing at...

Direct-to-Consumer service will initially offer access to COVID-19 molecular and antibody testing and will expand to include other testing in the future Enzo’s first-ever DTC testing...

Company reports $19.5 million in revenue and EPS of ($0.07) in the fourth quarter with significant margin expansion supported by rapid response to COVID-19 market opportunitiesQ1 21 first two months’...

Conference Call and Webcast Scheduled for October 13, 2020, 4:30 pm ET NEW YORK, NY, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics...

NEW YORK, NY, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it has expanded reagent and supply manufacturing...

NEW YORK, NY, July 21, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostic company, and Community Pharmacy Enhanced Services Network (CPESN® NY), the New...

Flexible Use on Three Platforms including Enzo’s Proprietary Automated GENFLEX™ Platform  NEW YORK, NY, July 13, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and...

First Collaboration under Enzo’s School and Institution Testing (“SIT”) Program NEW YORK, NY, June 30, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and...

Continues to Explore Opportunities for Use of the Compound as a Potential Treatment for COVID-19 NEW YORK, NY, June 23, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading...

Revenue of $17 million and EPS of ($0.21) due to COVID-19 impactAchieved major milestone with launch of comprehensive COVID-19 program for virus screening and antibody testing NEW YORK, June 08,...